Method Improves Risk Assessment for Lung Cancer Screening
The approach improved risk assessment compared with 2021 USPSTF screening criteria.
Lung Cancer
Stat Consult: Small Cell Lung Cancer
This review provides a concise overview of the epidemiology, etiology, history, diagnostic criteria, and management of small cell lung cancer.
Updated Screening Guidelines for 5 Cancer Types
An update on the available cancer screening guidelines, benefits/limitations, and risks for cervical, breast, prostate, colon, and lung cancers.
Smoking History May Predict Immune Checkpoint Inhibitor Outcomes in Metastatic Non-Small Cell Lung Cancer
A detailed smoking history may help to inform patient outcomes.
Lung Cancer Screening Project Improves Testing in North Carolina County
A practice improvement project increased lung cancer screening rates among eligible Medicaid recipients in a rural primary care practice in North Carolina.
Chemotherapy Improves Survival in Older Patients With NSCLC
Use of chemotherapy among patients aged 80 years and older with metastatic non-small cell lung cancer (NSCLC) was linked to longer overall survival.
Opdivo No Longer FDA-Approved for Small Cell Lung Cancer
In 2018, the FDA granted accelerated approval to Opdivo for SCLC based on data from the phase 1/2 CheckMate -032 trial.
AI Model Using Chest X-Ray May Predict 12-Year Lung Cancer Risk
A deep learning model based on chest radiograph images and electronic medical record data shows promise for smokers at high risk for lung cancer
USPSTF Advises Annual Low-Dose CT Lung Screening for High-Risk Individuals
USPSTF recommends annual low-dose computed tomography screening for people aged 50 to 80 years at high lung cancer risk due to smoking history.
Adherence to USPSTF Lung Cancer Screening Recommendations
12.5 percent of those meeting USPSTF recommendations for low-dose CT had screening exam in past year.
- Loading...
Loading...
Next post in Oncology Information Center
Loading... 
Loading...